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The mechanism of resistance of keratinocytes to ultraviolet A (UVA) (320–400 nm)-induced oxidative damage has
not yet been elucidated. Here, we examined the possible link between the intracellular level of the labile iron pool
(LIP) and the susceptibility to UVA-induced cell death using a series of human skin ﬁbroblast and keratinocyte cell
lines as a model. Resistance of keratinocytes to UVA-induced cell death was conﬁrmed by ﬂow cytometry and in
ﬁbroblasts necrosis was found to be the primary mode of cell death induced by UVA. The percentage of necrosis in
ﬁbroblasts also correlated with the extent of intracellular ATP depletion, a hallmark of necrotic cell death. The
evaluation of the intracellular level of LIP by calcein assay revealed that both ‘‘basal’’ and ‘‘UVA-induced’’ levels of
LIP in keratinocytes were several fold lower than in ﬁbroblasts. Accordingly the dose to give an equivalent level of
necrosis was several fold lower in ﬁbroblasts than in keratinocytes. Furthermore, the modulation of ‘‘basal’’ or
‘‘UVA-induced’’ level of LIP by either Desferal and/or hemin treatment significantly affected the extent of UVA-
induced necrotic cell death and ATP depletion in all the cell lines. Cellular susceptibility to UVA-induced necrotic
cell death appears to reﬂect the intracellular level of LIP.
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Both acute and chronic exposure to sunlight, elicits many
adverse effects in the skin. The acute response has been
shown to cause immediate effects such as erythema, sun-
burn, pigmentation, hyperplasia, and immunosuppression,
and the chronic response has been associated with delayed
effects such as skin aging and cancer (Tyrrell, 1991, 1996;
Gasparro et al, 1998; Pourzand and Tyrrell, 1999). Never-
theless, the cellular mechanisms underlying such risks are,
at present, not fully understood. It is known, however, that
most of these effects are wavelength dependent and usually
occur as the result of cumulative solar ultraviolet (UV) dose.
The identification of specific cellular events following irra-
diation with the UV component of sunlight is, therefore,
likely to provide clues as to the mechanism of the devel-
opment of such pathologies. Our recent discovery that
ultraviolet A (UVA) (320–400 nm) radiation, the oxidizing
component of sunlight leads to an immediate measurable
increase in potentially harmful ‘‘labile’’ iron in a human skin
fibroblast cell line, FEK4, provides a new insight into UVA-
induced skin damage, since iron is a catalyst of biological
oxidations (Pourzand et al, 1999). Indeed, labile iron, due to
its bioavailability in biological systems, plays an essential
role in the promotion of the pro-oxidant condition in cells,
especially at strategic cellular targets such as cell mem-
branes, since it can undergo redox cycling thereby generate
toxic oxidants such as hydroxyl radical and lipid-derived
alkoxyl and peroxyl radicals, and elicit biological damage
(Aust et al, 1985; Morliere et al, 1991; Punnonen et al, 1991;
Halliwell and Gutteridge, 1992; Vile and Tyrrell, 1995). Cel-
lular iron levels are therefore tightly regulated in order to
maintain an adequate substrate whereas also minimizing
the pool of potentially toxic labile iron, the so-called labile
iron pool (LIP). Iron belonging to this intracellular pool is
considered to be in a steady-state equilibrium, loosely
bound to low molecular weight compounds such as ATP or
citrate, accessible to permeant chelators and metabolically
and catalytically reactive (Breuer et al, 1996; Epsztejn et al,
1997; Cairo and Pietrangelo, 2000; Petrat et al, 2001). Al-
terations in LIP are normally sensed by the cytosolic iron
regulatory proteins 1 and 2 which function as post-tran-
scriptional regulators of both iron uptake via the transferrin
receptor and iron sequestration by the iron storage protein,
ferritin (Ft). When iron is scarce in the LIP, Ft, and transferrin
receptor mRNAs are specifically recognized and bound by
the active forms of iron regulatory proteins, leading to stab-
ilization of the transferrin receptor mRNA and inhibition of Ft
translation, both of which will lead to enhanced levels of LIP.
Conversely, during an increase in iron supply, iron regulatory
proteins are converted to a low-affinity mRNA-binding pro-
tein, leading to the induction of Ft mRNA translation and the
degradation of transferrin receptor mRNA, which will ulti-
mately lead to a reduction in the LIP (Beinert and Kennedy,
1993; Klausner et al, 1993; Kuhn, 1994; Guo et al, 1995;
Hentze and Kuhn, 1996).
Under pathological conditions, including oxidative
stress, iron homeostasis is severely altered (Cairo et al,
1995, 1996; Martins et al, 1995; Pantopoulos and Hentze,
Abbreviations: CA, calcein; DFO, Desferal; Ft, ferritin; LIP, labile
iron pool; PI, propidium iodide; SD, standard deviation; UVA, ul-
traviolet A
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1995; Pourzand et al, 1999). The release of potentially
harmful ‘‘labile’’ iron within cells by UVA radiation should
exacerbate the damaging effects of the UVA-induced oxi-
dative stress and is likely to be of central importance to both
the reversible and degenerative damage to skin cells that
follows exposure to solar UVA. Furthermore, UVA induces
the rapid proteolytic degradation of the major iron storage
protein, Ft, as a result of destabilization of lysosomal mem-
branes and the subsequent leakage of proteolytic enzymes
from these organelles. The lack of this critical iron-storage
protein is expected to further exacerbate the consequences
of the UVA-released iron in human cells.
The upper layer of skin (epidermis) receives high levels of
UV radiation on sunlight exposure and is a major target for
the carcinogenic events in the skin. It has generally been
observed that skin keratinocytes are more resistant to UVA-
mediated membrane damage (Applegate et al, 1995; Mo-
rliere et al, 1997) and cytotoxicity (Tyrrell and Pidoux, 1988)
than fibroblasts, although the underlying mechanism is yet
to be determined. Since UVA-induced iron release might be
an important factor for skin damage, we hypothesized that
the higher resistance of human keratinocytes to UVA radi-
ation may be related to the lower level of UVA-mediated
labile iron release in these cells and therefore sought to fur-
ther characterize this phenomenon in both skin fibroblasts
and keratinocytes following exposure to UVA irradiation.
Results
Determination of basal LIP in ﬁbroblast and keratinocyte
cell lines In order to compare the absolute basal level of
LIP in both fibroblast and keratinocyte cell lines, the disso-
ciation constant (Kd) of calcein (CA)-bound iron (CA-Fe) was
first determined in CA-loaded cells of both types using the
CA fluorescent assay. The results were then expressed as
‘‘LIP’’ which is operationally defined as the sum of concen-
trations of free CA-unbound iron [Fe] and CA-bound iron
[CA-Fe] (see Materials and Methods and Epsztejn et al,
1997). These results (Table Ia and b) demonstrate that
overall the basal LIP levels in fibroblasts (i.e., between
1.21  0.45 and 2.01  0.06 mM; Table Ia) are several fold
higher than in keratinocytes cell lines (i.e., between
0.27  0.03 and 0.52  0.17 mM; Table Ib) used in this study.
Determination of LIP levels following irradiation of both
ﬁbroblast and keratinocyte cell lines with a range of
doses of UVA In order to estimate the extent of LIP release
following radiation treatment, both fibroblast and keratin-
ocyte cell lines were exposed to a range of doses of UVA
irradiation at natural exposure levels (i.e., 250 and 500 kJ
per m2). The results (Table S1a and b, see online supple-
ment) reveal that although UVA promotes a concentration-
dependent increase in labile iron in both fibroblast and
keratinocyte cell lines, the absolute values of LIP in UVA-
irradiated keratinocytes remain several fold lower than in
UVA-irradiated fibroblasts.
The kinetics of UVA-induced increase in LIP in ﬁbro-
blasts and keratinocyte cell lines The kinetics of iron
mobilization in both fibroblast (i.e., FEK4 and IBR3) and
keratinocyte (HaCaT, HFK-SV61) cell lines was followed us-
ing the CA assay up to 48 h post-irradiation time with a UVA
dose of 250 kJ per m2. The results (Table IIa and b) showed
that in both fibroblast and keratinocyte cell lines, the
immediate increase in LIP is sustained up to 2 h after
irradiation and returns to approximately the control value at
Table I. Determination of basal LIP
Cell line-condition [Fe] lM [CA-Fe] lM LIP¼ [Fe]þ [CA-Fe] lM
(a) Fibroblast cell linesa
FEK4 1.07  0.41 0.14  0.05 1.21  0.45
IBR3 1.79  0.38 0.21  0.07 1.99  0.40
FCP4 1.69  0.67 0.15  0.04 1.85  0.40
FCP5 1.28  0.55 0.12  0.03 1.42  0.28
FCP7 1.82  0.13 0.18  0.01 2.01  0.06
FCP8 1.51  0.45 0.16  0.02 1.67  0.21
(b) Keratinocyte cell linesb
HaCaT 0.34  0.05 0.16  0.04 0.50  0.06
HFKSV61 0.32  0.09 0.20  0.07 0.52  0.17
KCP4 0.43  0.01 0.01  0.00 0.44  0.00
KCP5 0.49  0.06 0.02  0.00 0.51  0.04
KCP7 0.25  0.04 0.01  0.00 0.27  0.03
KCP8 0.30  0.07 0.02  0.00 0.31  0.17
Note: Measurements were performed in unirradiated samples (0 kJ per m2).The concentrations of Fe, CA-Fe and LIP are expressed as means  SD,
n¼ 3–6.
aKd of CA-Fe for FEK4 and IBR3 were 12.7 and 19.1, respectively. Kd of CA-Fe for FCP4, FCP5, FCP7 and FCP8 was 9.9 (see Materials and Methods).
bKd of CA-Fe for HaCaT and HFK-SV61 were 9. 8 and 4.5, respectively. Kd of CA-Fe for KCP4, KCP5, KCP7 and KCP8 was 6.02 (see Materials and
Methods).
LIP, labile iron pool; Kd, dissociation constant; Fe, free iron; CA-Fe, calcein-bound iron.
772 ZHONG ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
6 h post-irradiation. The CA assay performed 24 or 48 h
after UVA irradiation of either fibroblasts or keratinocytes
reveal no further change in LIP concentration. These results
illustrate that the kinetics of LIP release in UVA-irradiated
keratinocytes is similar to that of fibroblasts.
Determination of the level of UVA-mediated cell death in
ﬁbroblasts In contrast to the extensive research on the
apoptotic effects of UVA (see Pourzand and Tyrrell, 1999),
the data on the effects of UVA on necrotic cell death are
limited. In particular, it is unclear whether UVA-induced iron
release can trigger necrotic cell death. Necrosis usually be-
gins by an impairment of the cells’ ability to maintain home-
ostasis leading to an influx of water and extracellular ions.
As a result, intracellular organelles, most notably the mi-
tochondria and lysosomes and ultimately the entire cell,
swell and rupture (i.e., undergo cell lysis). Due to the ulti-
mate breakdown of plasma membranes, the cytoplasmic
contents including lysosomal proteases are released into
the extracellular fluid. Therefore, in vivo, necrotic cell death
is often associated with extensive tissue damage resulting
in an intense inflammatory response. Since UVA promotes
both lysosomal (Pourzand et al, 1999) and plasma mem-
brane damage (see Tyrrell, 1996) and the extent of pro-
teolytic degradation of Ft and the consequent iron release is
related to the extent of UVA-mediated lysosomal membrane
damage (Pourzand et al, 1999), we hypothesized that UVA-
induced iron release might play a role in UVA-induced ne-
crotic cell death. To test this hypothesis, we evaluated the
percentage of apoptotic and necrotic cells in UVA-irradiated
fibroblast (i.e., FEK4, IBR3, and FCP8) and keratinocyte
(i.e., HaCaT, HFK-SV61, and KCP8) cell lines by flow
cytometry using the dual propidium iodide (PI) uptake/An-
nexin V-FITC binding assay. In the FEK4 fibroblast cell line,
which is known to be fairly resistant to UVA-induced
apoptosis (Pourzand and Tyrrell, 1999), we observe a
UVA-related concentration-dependent increase in necrotic
cell death (Fig 1a). Similarly, in both FCP8 and IBR3 fibro-
blast cells that are as resistant as FEK4 to UVA-induced
apoptosis, we observe a UVA-related concentration-de-
pendent increase in necrotic cell death (Fig 1b and c). Taken
together, it appears that necrosis is the predominant form of
cell death in skin fibroblasts when exposed to moderate to
high doses of UVA radiation.
Determination of the level of UVA-mediated cell death in
keratinocytes Since the concentration-dependent in-
crease in necrotic cell death in fibroblasts coincided with
the concentration-dependent increase in LIP (Table S1a,
see online supplement), a picture emerged suggesting a link
between the level of UVA-induced labile iron release and the
extent of UVA-mediated necrotic cell death. To examine this
hypothesis, the levels of apoptosis and necrosis were also
measured by flow cytometry in HaCaT, HFK-SV61, and
KCP8 keratinocyte cell lines that contained much lower
‘‘basal’’ and ‘‘UVA-induced’’ level of LIP than fibroblasts
(see Table S1a and b in online supplement). The results (Fig
1d–f ) reveal that keratinocyte cell lines, which are known to
be highly resistant to UVA-induced apoptosis (see Pourzand
and Tyrrell, 1999), are also resistant to necrosis leading us to
hypothesize that the low level of LIP in these cells might be
Table II. Kinetics of labile iron release following irradiation
with UVA
Cell line
conditionh
UVA
(kJ per m2)
Time (h)
Post-UVA [LIP] lM
Fold
increase
(a) Fibroblast cell lines
FEK4-00 0 – 1.21  0.45 1
FEK4-2500 250 0 2.46  0.67 2.14  0.51
FEK4-02–6 0 – 1.04  0.12 1
FEK4-2502 250 2 1.71  0.33 1.68  0.29
FEK4-2504 250 4 1.43  0.13 1.37  0.11
FEK4-2506 250 6 1.01  0.28 0.95  0.23
FEK4-024 0 – 1.13  0.22 1
FEK4-25024 250 24 1.07  0.28 0.95  0.12
FEK4-048 0 – 1.27  0.30 1
FEK4-25048 250 48 1.08  0.27 0.89  0.04
IBR3-00 0 – 1.99  0.41 1
IBR3-2500 250 0 4.06  0.44 2.11  0.52
IBR3-02–6 0 – 2.02  0.15 1
IBR3-2502 250 2 3.46  0.41 1.71  0.23
IBR3-2504 250 4 2.87  0.17 1.42  0.19
IBR3-2506 250 6 1.96  0.32 0.97  0.22
IBR3-024 0 – 1.92  0.35 1
IBR3-25024 250 24 1.64  0.45 0.85  0.13
IBR3-048 0 – 1.96  0.24 1
IBR3-25048 250 48 1.89  0.15 0.97  0.22
(b) Keratinocyte cell lines
HaCaT-00 0 – 0.50  0.06 1
HaCaT-2500 250 0 0.97  0.10 1.93  0.23
HaCaT-02–6 0 – 0.54  0.20 1
HaCaT-2502 250 2 0.84  0.35 1.60  0.33
HaCaT-2504 250 4 0.76  0.18 1.41  0.15
HaCaT-2506 250 6 0.53  0.12 1.07  0.37
HaCaT-024 0 – 0.65  0.16 1
HaCaT-25024 250 24 0.57  0.13 0.88  0.18
HaCaT-048 0 – 0.53  0.17 1
HaCaT-25048 250 48 0.51  0.20 0.95  0.15
HFK-00 0 – 0.52  0.17 1
HFK-2500 250 0 0.92  0.30 1.78  0.16
HFK-02–6 0 – 0.48  0.09 1
HFK-2502 250 2 0.81  0.15 1.65  0.22
HFK-2504 250 4 0.66  0.07 1.38  0.05
HFK-2506 250 6 0.50  0.11 1.04  0.06
HFK-024 0 – 0.52  0.09 1
HFK-25024 250 24 0.52  0.12 1.04  0.04
HFK-048 0 – 0.51  0.13 1
HFK-25048 250 48 0.49  0.06 0.96  0.10
Note: Measures were performed at indicated time (i.e., ‘‘h’’ in bold and
superscript) after irradiation with a UVA dose of 250 kJ per m2. The
concentrations of LIP are expressed as means  SD, n¼3–6.
Significantly different from sham-irradiated control, po0.05.
Significantly different from sham-irradiated control, po0.05.
UVA, ultraviolet A; LIP, labile iron pool.
ROLE OF LABILE IRON IN UVA-INDUCED NECROSIS 773123 : 4 OCTOBER 2004
responsible for their higher resistance to UVA-induced
necrotic cell death.
The modulation of the intracellular level of Ft and the
UVA-induced labile iron release by hemin or Desferal
(DFO) treatments Since iron released from Ft following its
proteolytic degradation by UVA appears to be a major
source of the UVA-induced increase in LIP (Pourzand et al,
1999), we sought to modulate the Ft content of the cells as
this was expected to modulate the level of UVA-induced
labile iron release, resulting from UVA-induced degradation
of the molecule. Indeed, iron loading of cells with hemin
(e.g., 20 mM, 18 h) is known to increase several fold the
intracellular level of Ft molecules so that the excess iron
could be stored and thereby the imbalance in LIP could be
stabilized (see Eisenstein et al, 1991; Cairo and Pietrangelo,
2000) (Table III and Fig 2, this study). Conversely, iron dep-
rivation in cells by DFO treatment (e.g., 100 mM, 18 h) is
known to decrease Ft iron (Ponka et al, 1998) and levels of
Ft synthesis (see Cairo and Pietrangelo, 2000) (Table III and
Fig 2, this study) leading to significant decreases in the
levels of intracellular LIP as monitored by strong IRP-1
binding activation in our previous study (Pourzand et al,
1999) and CA assay (see Pourzand et al, 1999 and Table S2
in online supplement) in this study.
So to ascertain the importance of the intracellular level of
LIP in modulating the susceptibility of skin cells to UVA-
induced necrotic cell death, both fibroblasts (i.e., FEK4,
IBR3, and FCP8) and keratinocytes (i.e., HaCaT, HFK-SV61,
and KCP8) were treated with either DFO, a strong iron
chelator, or hemin (ferric heme) for 18 h prior to radiation
treatment and then the level of LIP was measured following
radiation treatment using the CA assay. The results (Table
S2a and b, see online supplements) demonstrated that he-
min treatment alone (i.e., when not followed by irradiation)
does not modulate the level of LIP in either fibroblast or
keratinocyte cell lines. UVA irradiation of hemin-treated
cells, however, causes a concentration-dependent increase
in LIP (i.e., ‘‘UVA-induced’’ labile iron release) of up to 5-fold
of control values (Table S2a and b, see online supplement)
as a result of degradation of Ft molecules, the major source
of iron in the cells (see Fig 2). Furthermore, the comparison
of the increase in the level of ‘‘UVA-induced’’ labile iron re-
lease between fibroblast and keratinocyte cells reveal that
although the fold increase in both hemin-treated cell lines
is comparable, the UVA-induced LIP level in keratinocytes
remains several fold lower than in fibroblasts. In contrast,
DFO treatment prior to UVA radiation abolishes both the
‘‘basal’’ and ‘‘UVA-induced’’ levels of LIP in both fibroblast
and keratinocytes (Table S2a and b, see online supplement).
Figure 1
Effect of UVA radiation on the percentage of
necrosis and apoptosis in fibroblast and ker-
atinocyte cell lines. The percentage of apopto-
tic and necrotic cell death was scored by flow
cytometry 4 h following irradiation of cells with
UVA doses of 0, 100, 250, and 500 kJ per m2.
Values are means  SD (n¼3–8).
Table III. Effect of hemin or DFO treatment on the Ft content of
FEK4 versus HaCaT
Treatment
FEK4 (ng Ft
per mg protein)
HaCaT (ng Ft
per mg protein)
Control 93.70  9.4 19.7  6.2
5 mM hemin 217.5  22.3 37.2  12.9
20 mM hemin 399.8  53.6 44.3  8.30
100 mM DFO 17.81  6.7 Not detectable
Cells were pre-treated with 5 and 20 mM hemin and 100 mM DFO for 18
h as described in ‘‘Materials and Methods’’. The Ft levels were assayed
using an ELISA assay kit. The values are mean  SD of three observa-
tions.
Significance level when compared with non-treated control, po0.05.
DFO, Desferal; Ft, ferritin.
Figure2
Effect of DFO or hemin on Ft degradation (0 h) after UVA irradiation
of FEK4 cells. 35S-labeled FEK4 cells that were pre-treated for 18 h
with 20 mM hemin or 100 mM DFO were irradiated at 250 kJ per m2.
Immediately after UVA radiation, cells were lysed and immunoprecip-
itated with human polyclonal Ft antibody. The irradiated samples are
shown as (þ ). The non-irradiated controls are shown as ().
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The correlation between the level of UVA-induced iron
release and the extent of UVA-induced necrotic cell
death To investigate whether the modulation of the level of
UVA-induced labile iron release would modulate the extent
of UVA-induced necrotic cell death, both fibroblast (i.e.,
FEK4, IBR3, and FCP8) and keratinocyte (i.e., HaCaT, HFK-
SV61, and KCP8) cell lines were first treated with hemin
and/or DFO for 18 h and then exposed to a range of doses
of UVA radiation. Hemin treatment prior to UVA irradiation
dramatically increases the level of necrotic cell death
in fibroblasts, as shown in Fig 3. On the other hand, DFO
treatment prior to UVA radiation significantly protects
the fibroblasts against the UVA-mediated necrotic cell
death (Fig 3a–c). In keratinocytes, a concentration-depend-
ent increase in necrotic cell death is also observed in hemin
pre-treated cells following radiation treatment with a range
of doses of UVA (Fig 3d–f ). Taken together, these data
are in agreement with the hypothesis that UVA-induced
labile iron release plays a role in UVA-mediated necrotic
cell death.
The DFO treatment of keratinocytes prior to UVA does
not significantly modulate the level of UVA-induced necrotic
cell death (Fig 3d–f ) presumably because these cells are
naturally resistant to UVA-induced necrotic cell death and
they contain a low level of labile iron. So as a ‘‘control’’ to
Fig 3 and to ascertain that the low level of labile iron in these
cells was responsible for their resistance to UVA-induced
necrotic cell death, the keratinocytes (i.e., HaCaT, HFK-
SV61, and FCP8) were loaded with 20 mM hemin for 18 h
and then with DFO (1 mM) for 2 h to demonstrate that
modulation of the UVA-induced labile iron release by hemin/
DFO treatment should in turn modulate the level of
UVA-induced necrotic cell death when compared to he-
min-treated cells alone. The results (data not shown) con-
firmed that DFO treatment per se does not modulate the
level of UVA-induced necrotic cell death. DFO treatment of
cells that have been previously loaded with hemin for 18 h,
however, significantly decreases the level of UVA-induced
necrotic cell death when compared to hemin-treated cells
alone.
Determination of the intracellular level of ATP following
irradiation of both ﬁbroblast and keratinocyte cell lines
with UVA Since the immediate depletion of ATP in cells has
recently been identified as a hallmark of necrotic cell death
(e.g., Eguchi et al, 1997; Leist et al, 1997; Ha and Snyder,
1999), the intracellular levels of ATP was evaluated in both
fibroblasts (i.e., FEK4, IBR3, and CP8) and keratinocytes
(i.e., HaCaT, HFK-SV61, and KCP8), following UVA irradia-
tion using the Apoglow kit and a luminometer as described
in Material and Methods. The results reveal that in fibro-
blasts, UVA promotes the immediate depletion of cellular
ATP in a dose-dependent manner (Fig 4a–c). Furthermore,
the treatment of fibroblasts with DFO prior to UVA signif-
icantly decreases the ATP depletion in these cells. Con-
versely treatment of fibroblasts with hemin prior to a UVA
dose of 250 kJ per m2, significantly increases the depletion
of ATP in cells (Fig 4a–c). Interestingly, the pre-treatment of
fibroblasts with hemin completely abolishes the intracellular
ATP following the UVA dose of 500 kJ per m2 (data not
shown).
The correlation between the level of UVA-induced ATP
depletion and the extent of UVA-induced necrotic cell
death As controls for Apoglow assay and to mimic the
UVA-mediated ATP depletion, the intracellular level of ATP
was determined in FEK4 and IBR3 fibroblasts incubated
with either oligomycin alone (i.e., an inhibitor of the uncou-
pler-stimulated mitochondrial ATPase) in glucose-free me-
dium or combined with glucose (i.e., a source of glycolytic
ATP). The results (Fig S1a and c, see online supplement)
reveal that oligomycin decreases significantly the level of
ATP in FEK4 and IBR3 fibroblasts and that selective reple-
tion of the extra-mitochondrial pool with glucose can re-
store a portion of the oligomycin-mediated depletion of
intracellular ATP. Since the ATP depletion with oligomycin
was similar to the observation made with UVA, we sought to
determine whether selective and graded repletion of the
extra-mitochondrial ATP pool with glucose could prevent
both the UVA-mediated ATP depletion and the consequent
necrotic cell death. The results (Fig S1a–d, see online
Figure 3
Effect of hemin or DFO treatment on the UVA-
mediated necrotic cell death. Fibroblasts (a–c)
and keratinocyte (d–f ) cells treated for 18 h with
20 mM hemin or 100 mM DFO were irradiated with
UVA doses of 0, 100, 250, and 500 kJ per m2.
The percentage of necrotic cell death was scored
4 h following UVA by flow cytometry. Values are
means  SD (n¼3–5).
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supplement) confirm that graded repletion of FEK4 and
IBR3 fibroblasts with glucose prior to UVA treatment pre-
vents both the UVA-induced ATP depletion and necrotic cell
death. Taken together these results strongly suggested a
direct link between the UVA-induced cellular ATP depletion,
labile iron release and UVA-mediated necrotic cell death in
fibroblasts. Indeed, the depletion of LIP by DFO could res-
cue the fibroblast cells (i.e., FEK4, IBR3, and FCP8) from
both ATP depletion (Fig 4a–c) and necrotic cell death (Fig
3a–c). Also the presence of glucose either during oligomycin
or UVA treatment could rescue fibroblast cells from ATP
depletion and necrotic cell death (Fig S1a–d, see online
supplement), e.g., by restoring cellular glycolysis. Other
mechanisms (e.g., rescue via an increase in reducing equiv-
alents provided by NAD(P)H), however, cannot be excluded.
Finally, in keratinocytes (i.e., HaCaT, HFK-SV61, and
KCP8) that are known to be highly resistant to UVA-induced
necrotic cell death, there is no significant decrease in the
intracellular ATP levels following UVA radiation with a dose
of 500 kJ per m2 (i.e., with or without DFO, Fig 4d–f ). The
low level of UVA-mediated ATP depletion is in agreement
with the low level of necrosis in UVA-irradiated keratin-
ocytes. When cells are loaded with iron in the form of hemin
prior to UVA, however, a dramatic increase in ATP depletion
is observed (Fig 4d–f ). This increase in ATP depletion is also
accompanied by a significant increase in the percentage of
necrotic cell death (see Fig 3d–f of this manuscript and Fig
S2b and d, lane 7 in online supplement). Furthermore, glu-
cose supplementation of hemin-treated cells significantly
decreases the level of ATP depletion and the percentage of
necrotic keratinocytes (see Fig S2a–d, lane 8 in online sup-
plement).
Discussion
Previously, we have demonstrated that UVA induces an im-
mediate increase in labile iron in a human foreskin fibroblast
FEK4 cell line (Pourzand et al, 1999). This finding was based
on the observation that in FEK4 fibroblasts, UVA promoted
an immediate and concentration-dependent decrease in
IRP-1 binding activity that correlated with a concentration-
dependent increase in IRP-1 aconitase activity. The CA as-
say of the UVA-irradiated fibroblasts also confirmed that the
UVA-induced immediate decrease in IRP-1 binding activity
was due to an immediate increase in the level of chelatable
iron pool (i.e., [CA-Fe]). Furthermore, the pre-treatment of
cells with DFO prevented the UVA-mediated decrease in
IRP-1 binding activity and abolished the UVA-induced in-
crease in chelatable iron pool (Pourzand et al, 1999). These
findings prompted us to first characterize this phenomenon
further in a series of human skin fibroblast and keratinocyte
cell lines and then to investigate whether the UVA-induced
increase in LIP plays a role in increased susceptibility of
cells to UVA-induced damage.
Using the CA assay, we sought to determine the cell-
dependent Kd of [CA-Fe] in CA-loaded cells so that we
could compare the absolute ‘‘basal’’ or ‘‘UVA-induced’’ lev-
els of LIP among different cell lines. The data was then
expressed as ‘‘LIP’’ which is operationally defined as the
sum of free CA-unbound iron [Fe] and [CA-Fe]. The results
revealed that although the Kd of [CA-Fe] differs between
different cell lines, overall the level of [CA-Fe] and LIP is
several fold higher in fibroblasts when compared to kera-
tinocytes. These findings were in agreement with our pre-
vious observations with the IRP-1 bandshift assay showing
that the basal levels of IRP-1 binding activity in keratin-
ocytes were substantially higher than in fibroblasts, indi-
cating that keratinocytes possess lower levels of LIP than
fibroblasts (Pourzand et al, 1999 and unpublished data, this
laboratory).
In this study, we could also clearly demonstrate that la-
bile iron release occurs immediately following UVA irradia-
tion of both human skin fibroblasts and keratinocytes and is
sustained for at least 2 h following radiation treatment and
only returns to basal levels 6 h following irradiation. Previous
observations also demonstrated that UVA induces the rapid
proteolytic degradation of Ft within both fibroblasts and
keratinocytes (Pourzand et al, 1999 and unpublished data,
this laboratory). The lack of this critical iron storage protein
Figure 4
Effect DFO or hemin on the intracellular level
of ATP following UVA irradiation. Fibroblasts
(a–c) and keratinocyte (d–f) cells pre-treated (or
not) with 100 mM DFO (DF) or 20 mM hemin (Hm)
for 18 h were preincubated for 45 min in PNG
medium and then irradiated with a UVA dose of
250 or 500 kJ per m2 where indicated. The intra-
cellular level of ATP was measured 1 h following
UVA treatment with the Apoglow kit. Data are
given as percentages of non-treated control (C).
Values are means  SD (n¼3–4).
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during the first hours that follow irradiation is thought to
further exacerbate the consequences of the UVA-induced
iron release within human skin cells, since the excess of the
highly reactive LIP cannot be sequestered in the cells.
Although UVA promotes rapid release of potentially
harmful labile iron in both human fibroblasts and keratin-
ocytes, it was observed that both ‘‘basal’’ and ‘‘UVA-in-
duced’’ levels of LIP were several-fold higher in human skin
fibroblasts when compared with keratinocytes. Since iron
plays a crucial role in propagation of lipid peroxidation in
cellular membranes, it was hypothesized that the low level
of LIP in keratinocytes could be responsible for the higher
resistance of keratinocytes to UVA-induced membrane
damage and cytotoxicity. Previously, the investigation of
the correlation between the amount of UVA-mediated LIP
release and the rate of membrane damage in different cel-
lular organelles, i.e., plasma, lysosomes, and mitochondria
demonstrated that UVA promotes membrane damage in
both fibroblasts and keratinocytes (Pourzand et al, 1999
and unpublished data, this laboratory); however, the extent
of damage in keratinocytes is not as dramatic as in fibro-
blasts. Furthermore, in fibroblasts, DFO treatment, which is
known to significantly abolish the UVA-induced labile iron
release, protected the cells from UVA-mediated damage to
lysosomal, mitochondrial, and plasma membrane damage
(unpublished data, this laboratory). Similarly in this study,
we demonstrate that DFO treatment can also substantially
protect the fibroblasts against necrotic cell death (i.e., loss
of cell membrane integrity), consistent with the notion that
UVA-induced LIP release plays a key role in UVA-mediated
oxidative damage. Furthermore, based on the findings that
hemin loading of both fibroblasts and keratinocytes prior to
UVA radiation could increase the level of UVA-induced LIP
release, it was observed that hemin treatment of cells could
dramatically increase the level of UVA-induced lysosomal,
mitochondrial, and plasma membrane damage (unpub-
lished data, this laboratory) and the extent of UVA-mediated
necrotic cell death as shown by dual Annexin V/PI staining
in flow cytometry and intracellular ATP depletion by Apo-
glow assay. Taken together, these data indicate that the
level of UVA-induced LIP release in fibroblasts is directly
related to the extent of UVA-mediated membrane damage
and cytotoxicity.
This study provides new information on the molecular
mechanisms underlying UVA-mediated cell death in skin
cells. It appears that, in skin fibroblasts necrosis is the pre-
dominant form of cell death triggered by UVA and involves
labile iron as an intermediary. We propose the following se-
quence of events: UVA irradiation of skin fibroblasts causes
an immediate degradation of Ft and a consequent release
of labile iron. Since iron plays a crucial role as a catalyst
in destabilization of cellular membranes, the pool of iron
liberated mainly by Ft and possibly other sources upon
irradiation, will not only affect plasma and lysosomal
membranes but also will produce concomitant damage to
mitochondria (see Tyrrell, 1996; Pourzand and Tyrrell, 1999
and unpublished data, this laboratory) leading to abrupt
interruption of electron chain reactions within the mi-
tochondrial membrane and production of ROS as well as
depletion of mitochondrial ATP, all of which will lead to ne-
crotic cell death. It is now well established that the pro-
gression to necrotic or apoptotic cell killing following death
stimuli depends on the effect the mitochondrial membrane
damage has on cellular ATP levels (see Reed et al, 1998).
Indeed damage to mitochondrial membranes can trigger
both the abrupt opening of a high conductance permeability
transition pore in the mitochondrial inner membrane and
cytochrome c release from these organelles, both of which
could lead to interruption of electron chain transport caus-
ing the generation of reactive oxygen species, loss of the
electrochemical gradient across the inner membrane and
ATP depletion followed by necrosis (see Reed et al, 1998;
Reed, 1999). Previous observations from this laboratory
(Pourzand and Tyrrell, 1999 and unpublished data) have
shown that although UVA promotes both mitochondrial
damage and cytochrome c release in fibroblast cell lines
such as FEK4, these cell lines are particularly resistant to
UVA-induced apoptotic cell death. As the presence of ATP
is essential for the activation of apoptosis protease activat-
ing factor-1 (Apaf-1) and subsequent activation of caspases
that induce apoptosis (see Pourzand and Tyrrell, 1999), it
appears that the UVA-induced immediate depletion of ATP
in fibroblasts provides a rational explanation for the pre-
dominance of necrotic cell death induced by UVA. Previous
studies investigating the pathways of apoptotic cell death
induced by the non-membrane damaging agent stauros-
porine have established the importance of ATP in the switch
between apoptosis and necrosis. Indeed depletion of ATP
by compounds such as oligomycin switched the apoptotic
cell death to necrosis (e.g., Eguchi et al, 1997; Leist et al,
1997; Ha and Snyder, 1999), whereas repletion of ATP by
glucose or fructose (via glycolysis) in the oligomycin-treated
cells was able to restore the apoptotic cell death. This
study, however, reports on the role of ATP in cell death in-
duced by a primarily membrane damaging and necrotic cell
death stimulus, UVA.
In contrast in keratinocytes that possess both lower level
of basal LIP and Ft than fibroblasts, the absolute level of
UVA-induced labile iron remains several folds lower than in
fibroblasts and this contributes to the lower level of mi-
tochondrial damage, ATP depletion, and necrotic cell death
following radiation treatment. Several lines of evidence in
keratinocytes and fibroblasts strengthen the model that
links the intracellular level of LIP to the extent of membrane
damage, ATP depletion and necrotic cell death. Firstly,
UVA-mediated membrane damage to plasma, lysosomal
and mitochondrial membranes in human skin fibroblasts is
prevented in cells treated with iron chelators such as DFO,
and conversely is enhanced in iron-loaded cells (unpub-
lished data, this laboratory), demonstrating the crucial role
of labile iron in UVA-induced membrane damage. Secondly,
UVA-mediated necrotic cell death in skin fibroblasts ap-
pears to correlate with both mitochondrial and plasma
membrane damage, since both are prevented by DFO and
enhanced by hemin pre-treatments. Accordingly in keratin-
ocytes, the UVA-mediated necrotic cell death is enhanced
by hemin pre-treatment alone and prevented significantly by
a combined hemin/DFO pre-treatments. Thirdly, in both fib-
roblasts and keratinocytes, the level of UVA-induced labile
iron release appears to correlate with both UVA-induced
necrotic cell death and the immediate depletion of intracel-
lular ATP. Furthermore, these phenomena could be rescued
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either with glucose supplementation, possibly via glycolysis
or with DFO via prevention of UVA-induced labile iron
release and mitochondrial membrane damage. In contrast,
iron loading of both keratinocytes and fibroblasts with he-
min dramatically enhances both UVA-mediated ATP deple-
tion and necrotic cell death, in agreement with the notion
that the modulation of the intracellular level of LIP could
directly change the susceptibility of skin cells to UVA-in-
duced cell death.
Overall, these results provide substantial evidence that,
in keratinocytes, low ‘‘basal’’ and ‘‘UVA-induced’’ levels of
labile iron together with low level of Ft are likely to contribute
to their resistance to UVA-induced membrane damage and
necrotic cell death. Furthermore, UVA-induced damage to
skin cells (both fibroblasts and keratinocytes) appears to
reflect the level of the intracellular LIP.
Materials and Methods
Cell lines and culture The human fibroblast cell lines FCP4,
FCP5, FCP7, FCP8 and their respective matched keratinocyte cell
lines KCP4, KCP5, KCP7, KCP8 were derived from newborn fore-
skin explants (this laboratory). The two other human fibroblast cell
line used in this study were FEK4 (derived from a newborn foreskin
explants, this laboratory) and IBR3 (skin biopsy of a normal adult
individual aged 33 obtained from MRC Cell Mutation Unit, Bright-
on, UK). The transformed epidermal keratinocyte lines used in this
study were HFK-SV61 and HaCaT. HFK-SV61 was developed by
transfection of human fetal keratinocytes with the DNA of SV61, a
mutant of SV40, which lacks the origin of DNA replication (Parkin-
son and Newbold, 1980). HaCaT is a spontaneously immortalized
human skin keratinocyte cell line derived from adult back skin
(Boukamp et al, 1988). Both fibroblast (3.5  105) and keratinocyte
monolayers (2–3  105) were grown in 10 cm dishes for 3–4 days in
order to reach 80% confluency on the day of the experiment as
described previously (Tyrrell and Pidoux, 1986; Pourzand et al,
1999). The cells were passaged by trypsinization once a week. The
FCP and KCP cell lines were used for experiments between pas-
sages 4–8 and the fibroblast cell lines FEK4 and IBR3 were used
between passages 12–14.
Irradiation Irradiations were performed in PBS at approximately
251C using a broad spectrum Sellas 4kW UVA lamp (Sellas, Ger-
many), as described previously (Pourzand et al, 1999). The incident
dose was 300–350 W per m2, so a typical irradiation with a UVA
dose of 250 kJ per m2 would take around 12–14 min. UV doses
were measured using an IL1700 radiometer (International Light,
Newbury, Massachusetts). Control cells were treated in the same
manner, except that they were not irradiated.
Chemicals All the reagents were from Sigma Chemical (St Louis,
Missouri), except Pefabloc and Annexin V, (Roche, Lewes, UK),
protein G-Sepharose (Pharmacia, Uppsala, Sweden), desferrioxa-
mine mesylate (DFO from Novartis, Basel, Switzerland), and
calcein-AM (CA-AM, Molecular Probes, Eugene, Oregon). Cell cul-
tures materials were from Life Technologies (Paisley, Scotland) ex-
cept FCS (PAA Laboratories, Teddington, UK) and PBS (Oxoid,
Basingstoke, UK). Stock solutions were prepared in PBS, except
DFO and PI in water, salicylaldehyde isonicotinoyl hydrazone (SIH;
a kind gift from P. Ponka, Lady Davis Institute for Medical Re-
search, Montreal, Canada, see Baker et al, 1992) and hemin in
dimethyl sulfoxide. Final concentration of dimethyl sulfoxide in the
medium did not exceed 0.2%. The water used to prepare solutions
was from a Millipore purification system (Bedford, Massachusettts)
in order to minimize the presence of trace elements such as tran-
sition metals.
CA loading and intracellular LIP estimation The method used to
estimate the level of intracellular CA-bound iron (CA-Fe) was mod-
ified from Epsztejn et al (1997) as described previously (Pourzand
et al, 1999). To determine the intracellular level of LIP, that is op-
erationally defined as the sum of the intracellular level of CA-bound
iron (i.e., [CA-Fe]) and free iron (i.e., [Fe] unbound to CA), the cell-
dependent dissociation constant (Kd) for CA-Fe was determined by
addition of known amounts of ferrous ammonium sulfate to the
system (i.e., untreated/unirradiated or treated/irradiated cells) and
monitoring intensity of the fluorescence changes of the CA versus
the metal concentration (i.e., titration). The Kd values between un-
treated/unirradiated or treated/irradiated cells of the same type
were not significantly different (data not shown). The Kd values
among different cell types, however, varied according to the cell
type as follows: FEK4 (Kd¼ 12.7 median from n¼ 20), IBR3
(Kd¼ 19.6, median from n¼ 12), FCP4-8: (Kd¼ 9.99  0.38,
n¼ 6), HaCaT (Kd¼ 9.8 median from n¼ 6), HFK-SV61 (Kd¼ 4.5
median from n¼ 6) and KCP4-8 (Kd¼ 6.02  0.82, n¼ 6). The total
intracellular concentration of CA (i.e., [CA]t) in CA-loaded cells was
also calculated using the material conservation relationship and by
taking into account the volume of unit cells, i.e., the percentage of
cell packed volume divided by the number of cells as determined in
capillaries in a Haematocrit centrifuge. The cell volumes of the cell
lines used in this study were determined (in picolitre) as follows:
FEK4 (5.7  0.73), IBR3 (6.5  0.97), FCP4-8: (4.28  0.43),
HaCaT (3.2  0.32), HFK-SV61 (3.3  0.32), and KCP4-8
(1.97  021). From the Kd and [CA]t values, the absolute intracel-
lular level of free iron (i.e., [Fe] unbound to CA) was then calculated
and the results were expressed as micromolar concentration of LIP
(i.e., [CA-Fe]þ [Fe]). In all experiments the recorded CA leakage
from the supernatant of both unirradiated control and irradiated
cell suspension was always below 10%, so the total fluorescence
measured in cell suspension was the major fluorescence inside of
the cell.
Ferritin ELISA The level of Ft after specified treatments was de-
termined using a polyclonal (anti-Ft) ELISA kit known as the En-
zyme-Test Ferrritin kit (Roche, UK) as described previously (Vile
and Tyrrell, 1993). The protein concentration of the samples was
determined by Bradford assay with BioRad (Hertfordshire, UK) re-
agent kit (Bradford, 1976). The Ft content of each sample was
expressed as ng of Ft per mg of cytosolic protein (i.e., ng Ft per mg
protein).
Metabolic labelling in cultured cells Eighty percent confluent
FEK4 cells either treated for 18 h with DFO (100 mM), hemin (20 mM)
or none, were starved for 15 min in methionine-free minimum es-
sential media supplemented with 5% FCS followed by [35S]met-
hionine labelling for 4 h. The cells were then irradiated at a UVA
dose of 250 kJ per m2 as described above (the control cells were
treated as above, except that they were not irradiated) and lysed
as described previously (Pourzand et al, 1999). Equal amounts of
labelled proteins were immunoprecipitated by using anti-human Ft
polyclonal and Protein G-Sepharose and loaded on a 12% SDS-
polyacrylamide gel. After drying, the gel was exposed for autora-
diography.
Flow cytometry The percentage of apoptotic and necrotic cells
from a minimum of 10,000 cells (events) were scored after dual
staining of cells with PI and Annexin V-FITC staining by flow
cytometry using the FACS vantage (Becton Dickinson Frem-
bodegem-Aalst, Belgium). Briefly, after various treatments,
5  105 cells were harvested and incubated in 50 mL of incuba-
tion buffer (140 mM NaCl, 5 mM CaCl2 and 10 mM HEPES/NaOH,
pH 7.4) containing PI/Annexin V-FITC for 15 min at room temper-
ature. Cells were then diluted by addition of 450 ml incubation
buffer without PI/Annexin V and processed for flow cytometry us-
ing 488 nm excitation and a 515 nm band-pass filter for FITC de-
tection and a filter at 620 nm for PI detection. Double stained cells
were considered necrotic, whereas Annexin V positive/PI negative
778 ZHONG ET AL THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
cells were apoptotic. Annexin V negative/PI negative were the
‘‘Live’’ cells.
ATP measurement ATP concentrations in cells were determined
luminometrically using the Apoglow assay kit, as described by the
manufacturer (Lumitech, Nottingham, UK). Prior to experiments,
80% confluent cells were washed and resuspended in serum- and
glucose-free EMEM medium containing 2 mM pyruvate (PNG me-
dium) to allow oxidative phosphorylation. After adaptation to this
medium, cells were exposed to UVA at indicated doses or
oligomycin (2.5 mM for 45 min). Where indicated the medium was
supplemented with glucose (0.1–10 mM) in order to restore gly-
colytic ATP synthesis.
Statistical methods Results are expressed as the mean 
standard deviation (SD). Significant differences (po0.05) were de-
termined by either paired or unpaired t test after one-way analysis
of variance.
We thank Dr Stewart Abbott for precious advice on FACS analysis at
the early stages of the study, Dr Prem Ponka for SIH, Dr Sharmila
Basu-Modak for useful discussions and Mr Dave Vinicombe for his
excellent technical assistance. This research was supported by the
Association for International Cancer Research (UK) and by the UK De-
partment of Health (Contract no. 121/6378).
Supplementary Material
The following material is available from http://www.blackwellpublish-
ing.com/products/journals/suppmat/JID/JID23419/JID23419sm.htm
Figure S1
(a and c) Effect of glucose on the intracellular levels of ATP in
oligomycin or UVA-treated fibroblasts. For oligomycin treatment, cells
were pre-incubated for 45 min in PNG medium alone (C), or in the
presence of 0.2 mM oligomycin alone (Oli) or supplemented with 1 mM
glucose (G1Oli). For UVA experiments, cells that were preincubated for
45 min in PNG medium alone (i.e., C), or in the presence of 0.1, 0.5, 1,
and 10 mM glucose (i.e., G0.1, G0.5, G1, and G10, respectively) were
exposed to UVA dose of 500 kJ per m2. The intracellular level of ATP
was measured 1 h following oligomycin or UVA treatment with the
Apoglow kit. Data are given as percentages of non-treated control (i.e.,
C). (b and d ) Effect of glucose on the modulation of UVA-induced cell
death in fibroblasts. Cells pre-incubated for 45 min in PNG medium
alone (i.e., C), or in the presence of 1 (G1) and 10 mM (G10) glucose
were exposed to UVA dose of 500 kJ per m2. The level of apoptotic and
necrotic cell death was measured 4 h following UVA irradiation by flow
cytometry. Values are means  SD (n¼ 4–5). Significantly different
from untreated control, po0.05.
Figure S2
(a and c) Effect of glucose and/or hemin on the intracellular level of ATP
in UVA-treated keratinocytes. Cells pre-treated either with 20 mM hemin
(Hm), or not (C) were pre-incubated for 45 min in PNG medium and then
irradiated with a UVA dose of 500 kJ per m2 (UV). Where indicated,
medium was supplemented with 10 mM glucose (G10). The intracellular
level of ATP was measured 1 h following UVA treatment with the Apo-
glow kit. Data are given as percentages of non-treated control. (b and d)
Effect of glucose and/or hemin on the modulation of UVA-induced cell
death in keratinocytes. The level of apoptotic and necrotic cell death
was also measured 4 h following UVA irradiation by flow cytometry in
cells that had been treated as described in (a and c). Values are
means  SD (n¼3–4).
Table S1a. Modulation of LIP levels following irradiation of
ﬁbroblast cell lines with UVA
Table S1b. Modulation of LIP levels following irradiation of
keratinocyte cell lines with UVA
Table S2a. Effect of hemin or DFO treatment on UVA-induced
labile iron release in ﬁbroblasts
Table S2b. Effect of hemin or DFO treatment on UVA-induced
labile iron release in keratinocytes
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